Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI

J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI

Professor of Preventive Cardiology, National University of Ireland, Galway Campus; Medical and Research Director, National Institute for Prevention and Cardiovascular Health; Consultant Cardiologist, University College Hospital Galway, Saolta Healthcare Group, Galway, Ireland; Adjunct Faculty, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Dr. J. William ("Bill") McEvoy is Professor of Preventive Cardiology at the National University of Ireland, Galway campus, and a consultant cardiologist at University College Hospital Galway. He also serves as Medical and Research Director of the National Institute for Prevention and Cardiovascular Health. Prof. McEvoy is adjunct faculty at the Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, and at the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. He serves as the ESC National Coordinator for CVD Prevention, Ireland.

Prof. McEvoy is a Fellow of the Royal College of Physicians of Ireland. With a clinical interest in the primary and secondary prevention of cardiovascular disease, Prof. McEvoy's research focuses on testing novel biomarkers of risk and clinical epidemiology, with an emphasis on hypertension and atherosclerosis. His research has resulted in numerous peer-reviewed publications, grants, and awards. He is the co-Chair of the 2024 ESC Guideline on Arterial Hypertension.

Recent Contributions to PracticeUpdate:

  1. Intensive Blood Pressure Lowering in Patients With Malignant LV Hypertrophy
  2. Cumulative Systolic BP Load and Cardiovascular Risk in Patients With Diabetes
  3. Effect of Three Two-Drug Combinations of Antihypertensive Therapies on BP Variability in Black African Patients
  4. Effects of Blood Pressure According to Age on ESRD Development in Patients With Diabetes
  5. ACC 2022: Recommendations From Dr. J. William McEvoy
  6. Time in Target Range for Systolic BP Improves Cardiovascular Outcomes in Patients With HFpEF
  7. Effects of Regular Acetaminophen Dosing on BP in People With Hypertension
  8. 2021 Top Story in Cardiology: Salt in Hypertension—Recursive Themes in Research
  9. Reducing Sodium and Increasing Potassium Intake May Have CV Benefit
  10. Adding a New Medication vs Maximizing Dose to Intensify HTN Treatment in Older Adults

Recently Updated